USCA RIA’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$18.1M Buy
109,956
+2,106
+2% +$349K 1.1% 14
2021
Q1
$17.7M Buy
107,850
+16,039
+17% +$2.6M 1.17% 11
2020
Q4
$14.4M Buy
91,811
+768
+0.8% +$113K 1.01% 16
2020
Q3
$13.6M Buy
91,043
+914
+1% +$135K 1.06% 13
2020
Q2
$12.7M Buy
90,129
+315
+0.4% +$45.9K 1.12% 12
2020
Q1
$11.8M Buy
89,814
+16,697
+23% +$2.37M 1.37% 9
2019
Q4
$10.7M Sell
73,117
-1,130
-2% -$153K 0.95% 14
2019
Q3
$9.61M Buy
74,247
+5,020
+7% +$661K 0.94% 17
2019
Q2
$9.64M Buy
69,227
+8,012
+13% +$1.11M 0.98% 17
2019
Q1
$8.56M Buy
61,215
+7,638
+14% +$1.02M 0.93% 20
2018
Q4
$6.91M Sell
53,577
-11,273
-17% -$1.57M 0.92% 22
2018
Q3
$8.96M Sell
64,850
-6,105
-9% -$811K 0.91% 21
2018
Q2
$8.61M Buy
70,955
+7,327
+12% +$914K 0.92% 18
2018
Q1
$8.15M Buy
63,628
+9,372
+17% +$1.27M 0.9% 22
2017
Q4
$7.58M Buy
54,256
+5,232
+11% +$729K 0.84% 27
2017
Q3
$6.49M Hold
49,024
0.84% 26
2017
Q2
$6.49M Sell
49,024
-583
-1% -$74.4K 0.83% 26
2017
Q1
$6.18M Buy
49,607
+2,244
+5% +$268K 0.91% 19
2016
Q4
$5.46M Buy
47,363
+3,496
+8% +$404K 0.84% 23
2016
Q3
$5.18M Sell
43,867
-17,387
-28% -$2.11M 0.86% 17
2016
Q2
$7.43M Sell
61,254
-2,746
-4% -$312K 1.25% 11
2016
Q1
$6.92M Sell
64,000
-2,161
-3% -$224K 1.26% 11
2015
Q4
$6.8M Buy
66,161
+3,078
+5% +$310K 1.47% 7
2015
Q3
$5.89M Buy
63,083
+26,701
+73% +$2.58M 1.48% 6
2015
Q2
$3.55M Buy
36,382
+449
+1% +$45K 0.94% 25
2015
Q1
$3.62M Buy
35,933
+3,268
+10% +$332K 0.97% 24
2014
Q4
$3.42M Buy
32,665
+1,893
+6% +$199K 0.94% 24
2014
Q3
$3.28M Buy
30,772
+1,456
+5% +$151K 1% 17
2014
Q2
$3.07M Buy
29,316
+860
+3% +$86.9K 1.03% 19
2014
Q1
$2.79M Buy
28,456
+171
+0.6% +$15.9K 1% 20
2013
Q4
$2.59M Buy
28,285
+470
+2% +$43.3K 1.03% 19
2013
Q3
$2.41M Sell
27,815
-571
-2% -$51.2K 1.1% 17
2013
Q2
$2.44M Buy
+28,386
New +$2.41M 1.22% 18

Other funds holding JNJ

USCA RIA's JNJ Position: Q2 2021 in Review

USCA RIA increased its Johnson & Johnson (JNJ) stake by 2% in Q2 2021, buying an estimated $349K and bringing the position to 109,956 shares worth $18.1M. The position accounts for 1.1% of the portfolio, ranked #14.

USCA RIA first reported a position in JNJ in Q2 2013 and has held it in 33 quarters since. 3,324 funds tracked by Wall St. Rank hold JNJ as of Q2 2021.

  • USCA RIA held 109,956 shares of Johnson & Johnson worth $18.1M as of Q2 2021.
  • USCA RIA bought 2,106 Johnson & Johnson shares in Q2 2021, an estimated $349K.
  • Johnson & Johnson made up 1.1% of USCA RIA's portfolio in Q2 2021, its #14 holding.
  • USCA RIA first reported a position in Johnson & Johnson in Q2 2013 and has held it in 33 quarters since.
  • 3,324 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2021.

Based on USCA RIA's 13F filing for Q2 2021, filed 28 Jul 2021.